These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 29295463)

  • 1. Implementation of an Outsourced Transnational Service of Clinical Decision Support System.
    Teixeira V; Rubin L; Rebrij R; Tamborindeguy A; Martinez R; Bacigalupo JC; Luna D
    Stud Health Technol Inform; 2017; 245():1384. PubMed ID: 29295463
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-drug interaction checking assisted by clinical decision support: a return on investment analysis.
    Helmons PJ; Suijkerbuijk BO; Nannan Panday PV; Kosterink JG
    J Am Med Inform Assoc; 2015 Jul; 22(4):764-72. PubMed ID: 25670751
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature and frequency of drug therapy alerts generated by clinical decision support in community pharmacy.
    Heringa M; Floor-Schreudering A; Tromp PC; de Smet PA; Bouvy ML
    Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):82-9. PubMed ID: 26602064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of drug interactions and dosing in 484 neurological inpatients using clinical decision support software and an extended operational interaction classification system (Zurich Interaction System).
    Guzek M; Zorina OI; Semmler A; Gonzenbach RR; Huber M; Kullak-Ublick GA; Weller M; Russmann S
    Pharmacoepidemiol Drug Saf; 2011 Sep; 20(9):930-8. PubMed ID: 21774031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implementation of a clinical decision support system for computerized drug prescription entries in a large tertiary care hospital.
    Zenziper Y; Kurnik D; Markovits N; Ziv A; Shamiss A; Halkin H; Loebstein R
    Isr Med Assoc J; 2014 May; 16(5):289-94. PubMed ID: 24979833
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical decision support systems in community pharmacies: a scoping review.
    Moon J; Chladek JS; Wilson P; Chui MA
    J Am Med Inform Assoc; 2023 Dec; 31(1):231-239. PubMed ID: 37875066
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A critical evaluation of clinical decision support for the detection of drug-drug interactions.
    Smithburger PL; Buckley MS; Bejian S; Burenheide K; Kane-Gill SL
    Expert Opin Drug Saf; 2011 Nov; 10(6):871-82. PubMed ID: 21542665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical Decision Support System for PIM in Elderly Patients: Implementation and Initial Evaluation in Ambulatory Care.
    Frutos E; Kakazu M; Tajerian M; Gaiera A; Rubin L; Otero C; Luna D
    Stud Health Technol Inform; 2022 May; 294():475-479. PubMed ID: 35612125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of heterogeneous clinical decision support systems and their knowledge sets: feasibility study with Drug-Drug Interaction alerts.
    Kam HJ; Kim JA; Cho I; Kim Y; Park RW
    AMIA Annu Symp Proc; 2011; 2011():664-73. PubMed ID: 22195122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recommendations to improve the usability of drug-drug interaction clinical decision support alerts.
    Payne TH; Hines LE; Chan RC; Hartman S; Kapusnik-Uner J; Russ AL; Chaffee BW; Hartman C; Tamis V; Galbreth B; Glassman PA; Phansalkar S; van der Sijs H; Gephart SM; Mann G; Strasberg HR; Grizzle AJ; Brown M; Kuperman GJ; Steiner C; Sullins A; Ryan H; Wittie MA; Malone DC
    J Am Med Inform Assoc; 2015 Nov; 22(6):1243-50. PubMed ID: 25829460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative evaluation of the drug interaction screening programs MediQ and ID PHARMA CHECK in neurological inpatients.
    Zorina OI; Haueis P; Semmler A; Marti I; Gonzenbach RR; Guzek M; Kullak-Ublick GA; Weller M; Russmann S
    Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):872-80. PubMed ID: 22517594
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescriber response to computerized drug alerts for electronic prescriptions among hospitalized patients.
    Zenziper Straichman Y; Kurnik D; Matok I; Halkin H; Markovits N; Ziv A; Shamiss A; Loebstein R
    Int J Med Inform; 2017 Nov; 107():70-75. PubMed ID: 29029694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative performance of two drug interaction screening programmes analysing a cross-sectional prescription dataset of 84,625 psychiatric inpatients.
    Zorina OI; Haueis P; Greil W; Grohmann R; Kullak-Ublick GA; Russmann S
    Drug Saf; 2013 Apr; 36(4):247-58. PubMed ID: 23494998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of provider characteristics on the responses to medication-related decision support alerts.
    Cho I; Slight SP; Nanji KC; Seger DL; Maniam N; Fiskio JM; Dykes PC; Bates DW
    Int J Med Inform; 2015 Sep; 84(9):630-9. PubMed ID: 26004341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Performance Evaluation of Clinical Decision Support Systems (CDSS): Developing a Business Intelligence (BI) Dashboard.
    Teixeira V; Mori A; Usera A; Bacigalupo JC; Luna D
    Stud Health Technol Inform; 2019 Aug; 264():829-833. PubMed ID: 31438040
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical reasoning in the context of active decision support during medication prescribing.
    Horsky J; Aarts J; Verheul L; Seger DL; van der Sijs H; Bates DW
    Int J Med Inform; 2017 Jan; 97():1-11. PubMed ID: 27919368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of a machine learning capability for a clinical decision support system to enhance antimicrobial stewardship programs.
    Beaudoin M; Kabanza F; Nault V; Valiquette L
    Artif Intell Med; 2016 Mar; 68():29-36. PubMed ID: 26947174
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Standardized Rating Tool for Drug Alerts to Reduce Information Overload.
    Pfistermeister B; Sedlmayr B; Patapovas A; Suttner G; Tektas O; Tarkhov A; Kornhuber J; Fromm MF; Bürkle T; Prokosch HU; Maas R
    Methods Inf Med; 2016 Dec; 55(6):507-515. PubMed ID: 27782288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Better specification of triggers to reduce the number of drug interaction alerts in primary care.
    Heringa M; van der Heide A; Floor-Schreudering A; De Smet PAGM; Bouvy ML
    Int J Med Inform; 2018 Jan; 109():96-102. PubMed ID: 29195711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. What, if all alerts were specific - estimating the potential impact on drug interaction alert burden.
    Seidling HM; Klein U; Schaier M; Czock D; Theile D; Pruszydlo MG; Kaltschmidt J; Mikus G; Haefeli WE
    Int J Med Inform; 2014 Apr; 83(4):285-91. PubMed ID: 24484781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.